Abbott Laboratories Price Today
Abbott Laboratories
ABT
Healthcare
$187.20B
💰
Market Cap
32.7
💸
Price to Earnings
$3.3
🎉
EPS
+75
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
13 |
Strong Buy |
8 |
Hold |
8 |
Sell |
0 |
Strong Sell |
0 |
ABT Price Forecast Target
107.7 👉 136.0 +26%
ABT EPS Forecast
3.3 👉 4.6 +40%
Financials
Profit Margin
13 %
Revenue Growth
-11.4 %
Dividend
$ 2.04
Held Percent
0.5% - Insiders
76.4% - Institutions
23.1% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $16.8B
-
💰 Blackrock Inc. $14.6B
-
💰 Capital Research Global Investors $8.2B
-
💰 State Street Corporation $7.9B
-
💰 Capital International Investors $6.1B
Stock Ideas
Bill Ackman Portfolio
Bill Ackman, a renowned investor, has established himself as a long-term value investor with a keen eye for short-term price fluctuations. His expertise lies in special situations investments, and his Pershing Square portfolio reflects a highly conc…
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…
Warren Buffet Portfolio
Invest like the oracle himself! View the stocks that Warren Buffett holds in the Berkshire Hathaway portfolio.📮FAQ
Some Frequently Asked Questions.
The Abbott Laboratories industry is Medical Devices
The Abbott Laboratories sector is Healthcare
The Abbott Laboratories forecasted predicted Price to Earnings PE ratio is 23.3
The Abbott Laboratories Price to Earnings PE ratio is 32.7
The Market Capitalization of Abbott Laboratories is $187.20B
There are total of 1722186613 float shares with 76.4% held by Institutions and 0.5% held by insiders
The MAbbott Laboratories forecasted Earnings per Share EPS is $4.6
The Abbott Laboratories Earnings per Share EPS is 3.3
The Abbott Laboratories company has $24579000000 gross profits with 13 profit margins
The Abbott Laboratories Earnings Growth is -0.316% with -0.319% quarterly earnings growth
The Abbott Laboratories Revenue is $40226000896 with -0.114 revenue growth
The price target for Abbott Laboratories stock is $136.0 for the high target and $112.0 for the low target
The consensus analyst recommendations for Abbott Laboratories is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Abbott Laboratories is Buy, with the following breakdown:
- Buy: 13
- Strong Buy: 8
- Hold: 8
- Sell: 0
- Strong Sell: 0
The Beta of Abbott Laboratories is 0.7
The dividend of Abbott Laboratories is $2.04
The dividend yield of Abbott Laboratories is 0.019%
The biggest institutional and mutual fund holders of Abbott Laboratories stock are
- Vanguard Group Inc
- Blackrock Inc.
- Capital Research Global Investors
- State Street Corporation
The Abbott Laboratories ESG Score is 75, with the following breakdown:
- E: 3.03
- S: 13.59
- G: 8.36